Serologic Analysis of Human Rotavirus Serotypes P1A and P2 by Using Monoclonal Antibodies

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1993 Mar 1

PMID 7681440

Citations 33

Authors

L Padilla-Noriega

E R Mackow

M Gorziglia

G Larralde

K Taniguchi

H B Greenberg

Affiliations

Soon will be listed here.

Abstract

Three human rotavirus (HRV) VP4 serotypes and one subtype have been described on the basis of a fourfold or an eightfold-or-greater difference in neutralization titer when tested with hyperimmune antisera to recombinant VP4 or VP8* (serotypes P1A, P1B, P2, and P3). To start to analyze the antigenic basis underlying serotype specificity, we produced a library of 13 VP4-specific neutralizing monoclonal antibodies (NMAbs) to two HRVs, the serotype P1A strain Wa and the serotype P2 strain ST3, and characterized the reactivity of these NMAbs with a panel of serotypically diverse HRV strains by neutralization assay and enzyme-linked immunosorbent assay (ELISA). We characterized the serotypic specificity of the NMAbs by using a fourfold or an eightfold-or-greater difference in titer against the homologous (i.e., immunogen) and heterologous strains as a criterion for serotype. Some ST3-derived NMAbs reacted specifically with serotype P2 HRVs by ELISA and/or neutralization assay, while some Wa-derived NMAbs reacted specifically by ELISA and/or neutralization assay with some or all serotype P1A HRVs. Other Wa- and ST3-derived NMAbs reacted with some or all serotype P1A and P2 HRV strains by neutralization assay and ELISA. Most NMAbs did not react with serotype P1B or P3 strains. In previous studies, three distinct operationally defined epitopes have been identified on VP4 by examining the reactivity patterns of selected antigenic variants of HRV strain KU. At least one of the NMAbs described here recognizes an epitope unrelated to these previously identified epitopes, since it neutralized both KU and its variants.

Citing Articles

Functional refolding of the penetration protein on a non-enveloped virus.

Herrmann T, Torres R, Salgado E, Berciu C, Stoddard D, Nicastro D Nature. 2021; 590(7847):666-670.

PMID: 33442061 PMC: 8297411. DOI: 10.1038/s41586-020-03124-4.

Rotaviruses Associate with Distinct Types of Extracellular Vesicles.

Isa P, Perez-Delgado A, Quevedo I, Lopez S, Arias C Viruses. 2020; 12(7).

PMID: 32708544 PMC: 7411906. DOI: 10.3390/v12070763.

Actin-Dependent Nonlytic Rotavirus Exit and Infectious Virus Morphogenetic Pathway in Nonpolarized Cells.

Trejo-Cerro O, Eichwald C, Schraner E, Silva-Ayala D, Lopez S, Arias C J Virol. 2017; 92(6).

PMID: 29263265 PMC: 5827380. DOI: 10.1128/JVI.02076-17.

Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.

Sanchez-Tacuba L, Rojas M, Arias C, Lopez S J Virol. 2015; 89(23):12145-53.

PMID: 26401041 PMC: 4645303. DOI: 10.1128/JVI.01874-15.

Mutations in the rotavirus spike protein VP4 reduce trypsin sensitivity but not viral spread.

Trask S, Wetzel J, Dermody T, Patton J J Gen Virol. 2013; 94(Pt 6):1296-1300.

PMID: 23426355 PMC: 3709623. DOI: 10.1099/vir.0.050674-0.

References

Greenberg H, McAULIFFE V, Valdesuso J, Wyatt R, Flores J, Kalica A . Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun. 1983; 39(1):91-9. PMC: 347909. DOI: 10.1128/iai.39.1.91-99.1983. View

Beards G, Xu L, Ballard A, Desselberger U, McCrae M . A serotype 10 human rotavirus. J Clin Microbiol. 1992; 30(6):1432-5. PMC: 265305. DOI: 10.1128/jcm.30.6.1432-1435.1992. View

Midthun K, Greenberg H, Hoshino Y, Kapikian A, Wyatt R, Chanock R . Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol. 1985; 53(3):949-54. PMC: 254731. DOI: 10.1128/JVI.53.3.949-954.1985. View

Taniguchi K, URASAWA S, Urasawa T . Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. J Gen Virol. 1985; 66 ( Pt 5):1045-53. DOI: 10.1099/0022-1317-66-5-1045. View

Shaw R, Estes M, Greenberg H . Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol. 1985; 22(2):286-91. PMC: 268377. DOI: 10.1128/jcm.22.2.286-291.1985. View

Lazdins I, Sonza S, Dyall-Smith M, Coulson B, HOLMES I . Demonstration of an immunodominant neutralization site by analysis of antigenic variants of SA11 rotavirus. J Virol. 1985; 56(1):317-9. PMC: 252539. DOI: 10.1128/JVI.56.1.317-319.1985. View

Gorziglia M, Hoshino Y, Buckler-White A, Blumentals I, Glass R, Flores J . Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc Natl Acad Sci U S A. 1986; 83(18):7039-43. PMC: 386648. DOI: 10.1073/pnas.83.18.7039. View

Offit P, Clark H, Blavat G, Greenberg H . Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol. 1986; 60(2):491-6. PMC: 288917. DOI: 10.1128/JVI.60.2.491-496.1986. View

Flores J, Midthun K, Hoshino Y, Green K, Gorziglia M, Kapikian A . Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol. 1986; 60(3):972-9. PMC: 253335. DOI: 10.1128/JVI.60.3.972-979.1986. View

10.

Shaw R, Vo P, Offit P, Coulson B, Greenberg H . Antigenic mapping of the surface proteins of rhesus rotavirus. Virology. 1986; 155(2):434-51. DOI: 10.1016/0042-6822(86)90205-9. View

11.

Taniguchi K, Morita Y, Urasawa T, URASAWA S . Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. J Virol. 1987; 61(5):1726-30. PMC: 254165. DOI: 10.1128/JVI.61.5.1726-1730.1987. View

12.

Mackow E, Shaw R, Matsui S, Vo P, Dang M, Greenberg H . The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A. 1988; 85(3):645-9. PMC: 279611. DOI: 10.1073/pnas.85.3.645. View

13.

Taniguchi K, Maloy W, Nishikawa K, Green K, Hoshino Y, URASAWA S . Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol. 1988; 62(7):2421-6. PMC: 253400. DOI: 10.1128/JVI.62.7.2421-2426.1988. View

14.

Gorziglia M, Green K, Nishikawa K, Taniguchi K, Jones R, Kapikian A . Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol. 1988; 62(8):2978-84. PMC: 253736. DOI: 10.1128/JVI.62.8.2978-2984.1988. View

15.

Losonsky G, Rennels M, Lim Y, Krall G, Kapikian A, Levine M . Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. Pediatr Infect Dis J. 1988; 7(6):388-93. DOI: 10.1097/00006454-198806000-00004. View

16.

Svensson L, Padilla-Noriega L, Taniguchi K, Greenberg H . Lack of cosegregation of the subgroup II antigens on genes 2 and 6 in porcine rotaviruses. J Virol. 1990; 64(1):411-3. PMC: 249117. DOI: 10.1128/JVI.64.1.411-413.1990. View

17.

Estes M, Cohen J . Rotavirus gene structure and function. Microbiol Rev. 1989; 53(4):410-49. PMC: 372748. DOI: 10.1128/mr.53.4.410-449.1989. View

18.

Mackow E, Yamanaka M, Dang M, Greenberg H . DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites. Proc Natl Acad Sci U S A. 1990; 87(2):518-22. PMC: 53296. DOI: 10.1073/pnas.87.2.518. View

19.

Padilla-Noriega L, Arias C, Lopez S, Puerto F, Snodgrass D, Taniguchi K . Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol. 1990; 28(6):1114-9. PMC: 267887. DOI: 10.1128/jcm.28.6.1114-1119.1990. View

20.

Gorziglia M, Larralde G, Kapikian A, Chanock R . Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci U S A. 1990; 87(18):7155-9. PMC: 54702. DOI: 10.1073/pnas.87.18.7155. View